Discovery could pave way to new treatment for rare jaw tumor

Researchers at the Stanford University School of Medicine have identified the mutations underlying a rare, understudied type of jaw tumor called ameloblastoma. In a paper published online May 25 in Nature Genetics, the researchers identify mutations in two genes that are associated with 80 percent of ameloblastoma cases. Read more here.